Incorporation of Urinary Prostate Cancer Antigen 3 and TMPRSS2: ERG into Prostate Cancer Prevention Trial Risk Calculator

BACKGROUND: The Prostate Cancer Prevention Trial Risk Calculator (PCPTRC) is a commonly used risk tool for predicting the outcome on biopsy based on the established risk factors. OBJECTIVE: To determine whether incorporation of the novel urinary markers prostate cancer antigen 3 (PCA3) and TMPRSS2:E...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Urol Focus
Autors principals: Ankerst, Donna P., Goros, Martin, Tomlins, Scott A., Patil, Dattatraya, Feng, Ziding, Wei, John T., Sanda, Martin G., Gelfond, Jonathan, Thompson, Ian M., Leach, Robin J., Liss, Michael A.
Format: Artigo
Idioma:Inglês
Publicat: 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6077104/
https://ncbi.nlm.nih.gov/pubmed/29422418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.euf.2018.01.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars